Efficient Synthetic Access to a New Family of Highly Potent Bryostatin Analogues via a Prins-Driven Macrocyclization Strategy

Documenti analoghi

• Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro
  di: DeChristopher, Brian A., et al.
  Pubblicazione: (2012)
• Lead Diversification through a Prins-Driven Macrocyclization Strategy: Application to C13-Diversified Bryostatin Analogues
  di: Wender, Paul A., et al.
  Pubblicazione: (2013)
• Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
  di: Marsden, Matthew D., et al.
  Pubblicazione: (2018)
• Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity
  di: Wender, Paul A., et al.
  Pubblicazione: (2011)
• Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death
  di: Staveness, Daryl, et al.
  Pubblicazione: (2016)